Skip to main content

Table 4 Prediction of all-cause mortality after adding continuous or dichotomous E-cadherin measurements to standard diagnostic tests of cancer cell detachment from colorectal primary tumors (n = 188)

From: Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors

 

E-cadherin Variable Added to Standard Tests

  

Dichotomous E-cadherin Cut Point

Continuous

0.52

0.60

0.85

C-Index, % (95% CI)a

66 (58, 72)

51 (41, 59)

54 (45, 62)

56 (48, 63)

Reclassification Metricb

 Number (%) moved to higher risk category

47 (25)

11 (6)

27 (14)

41 (22)

 Number (%) moved to lower risk category

55 (29)

93 (49)

83 (44)

70 (37)

 Total number (%) reclassified

102 (54)

104 (55)

110 (59)

111 (59)

 Reclassification Calibration Statistic P-value

0.1

0.1

0.1

0.2

 Event Net Reclassification Index, % (95% CI)

14 (−11, 30)

−22 (−38, −7)

−7 (−23, 10)

3 (−15, 21)

 Non-Event Net Reclassification Index, % (95% CI)

13 (3, 35)

54 (44, 63)

41 (29, 52)

24 (12, 37)

 Integrated Discrimination Improvement, % (95% CI)

3.4 (1.9, 5.6)

4.3 (2.2, 6.8)

3.4 (1.8, 5.3)

3.7 (1.7, 5.9)

  1. E-cadherin measured on a continuous average intensity scale of 0–3, then modeled as either continuous or dichotomized (EMT positive versus EMT negative) at a given cut point. For dichotomous E-cadherin, EMT positive status was expression below the cut point while EMT negative status was expression at or above the cut point. 62 subjects died within 5 years of diagnosis
  2. aEach c-index value in the table is for a Cox model estimating 5-year risk of all-cause mortality based on standard diagnostic tests of cancer cell detachment (lymph node evaluation and radiologic imaging) plus the respective continuous or dichotomous E-cadherin variable. C-index for a model of standard diagnostic tests only was 45% (95% CI 36%, 53%)
  3. bReclassification metrics compare a Cox model estimating 5-year risk of all-cause mortality based on standard diagnostic tests of cancer cell detachment (lymph node evaluation and radiologic imaging) to a Cox model based on standard diagnostic tests plus continuous or dichotomous E-cadherin status defined by a given cut point. Mortality risk categories were 0 – 20%, 20 – 30%, 30 – 40%, and > 40%